What ‘emergency use’ of COVID-19 vaccine means for Americans

WASHINGTON — We could see the first shots for COVID-19 as early as next month, but initial supplies will be scarce and rationed.

Pfizer is asking U.S. regulators to allow emergency use of its COVID-19 vaccine after announcing the shot appears 95% effective. So, what does that mean exactly for U.S. citizens.

On Dec. 10, Americans will have their first chance to hear about the evidence. That’s when the FDA’s scientific advisers are expected to meet.

Days before the meeting, the FDA will release its own internal analysis, setting the stage for the advisers’ debate.

The FDA’s decision isn’t just based on data from its ongoing study, but also whether the vaccine is being made correctly. The FDA can grant emergency use authorization before final testing is fully complete.

Not far behind Pfizer is Moderna’s COVID-19 vaccine. Early data released by the company suggests the shots are as strong as Pfizer’s.

British archeologist says its possible Jesus’ boyhood home has been found (NCD)

Cox Media Group